Through these experiments, we discovered that the glioma-like lesions induced by mutant ACVR1, H3.1K27M, and p53 loss express a mesenchymal phenotype based on the expression of CD44, CD31, pSTAT3, Iba1, vimentin, and minimal Olig2 expression. Here, CD44 is linked to glioma.